What is the recommended emergency department medication regimen and dosing for an adult presenting with an acute migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Department Migraine Cocktail: Recommended Medications and Doses

For adults presenting to the ED with acute migraine requiring parenteral therapy, administer prochlorperazine 10 mg IV or metoclopramide 10 mg IV as first-line treatment, combined with ketorolac 30-60 mg IV or dexketoprofen IV, plus dexamethasone 10-24 mg IV to prevent recurrence 1, 2.

First-Line Parenteral Regimen

Primary Agents (Choose One Dopamine Antagonist)

  • Prochlorperazine: 10 mg IV (Level A - must offer) 1, 2

    • Most robust evidence with multiple class I studies
    • Effectively relieves headache pain directly, not just nausea 3
  • Metoclopramide: 10 mg IV (Level B - should offer) 1, 2

    • Administer 20-30 minutes before or with other agents 3
    • Provides both analgesia and treats gastric motility impairment

Critical Pitfall: Monitor for dystonic reactions with both agents; have diphenhydramine available 3.

Add NSAID Component

  • Ketorolac: 30-60 mg IV or IM 3, 1

    • Rapid onset, approximately 6-hour duration
    • Rebound headache unlikely 3
    • Maximum 120 mg/day, treatment not to exceed 5 days 3
  • Dexketoprofen: IV (Level B - should offer) 1

    • Highly likely to be effective based on multiple class I studies

Contraindications: Avoid NSAIDs in aspirin/NSAID-induced asthma, active GI bleeding, cerebrovascular hemorrhage 3.

Recurrence Prevention

  • Dexamethasone: 10-24 mg IV (Level B - should offer) 2
    • Multiple class I studies support use to prevent headache recurrence
    • Essential component of discharge planning

Alternative First-Line Options

For Patients Requiring Migraine-Specific Therapy

  • Sumatriptan: 6 mg subcutaneous (Level A - must offer) 1, 2
    • Peak concentration in 15 minutes
    • Effective in 70-82% of patients 3
    • Contraindications: Ischemic vascular disease, vasospastic coronary disease, uncontrolled hypertension 3

For Patients with Prominent Nausea/Vomiting

Use non-oral routes of administration 3:

  • Sumatriptan 6 mg SC
  • Prochlorperazine 25 mg suppository (maximum 3 doses per 24 hours) 3
  • Consider greater occipital nerve block (GONB) - Level A recommendation 1

Second-Line Therapies (When First-Line Fails)

Evidence-Based Options

  • Chlorpromazine: IV (Level C - may offer) 1
  • Valproate sodium: 500-1000 mg IV 4
    • Effective for moderate to severe or treatment-resistant migraine
  • Dihydroergotamine (DHE): 0.5-1.0 mg IV/IM 3, 4
    • Can repeat every hour to maximum 3 mg IM or 2 mg IV per day
    • Maximum 6 mg per week
    • Contraindications: Pregnancy, concurrent triptan use, beta blockers 3

Nerve Blocks

  • Greater Occipital Nerve Block (GONB): Level A - must offer 1
    • Highly likely effective based on multiple class I studies
  • Supraorbital Nerve Block (SONB): Level B - should offer 1

What NOT to Use

Avoid as first-line therapy (Level A - must not offer):

  • Hydromorphone IV 1, 2
  • Morphine 2
    • Concern about dependency, rebound headaches, and loss of efficacy 3
    • No evidence demonstrating efficacy and concern about long-term sequelae 2

Likely ineffective:

  • Propofol IV 1, 5
  • Paracetamol (acetaminophen) IV alone 1

Insufficient evidence:

  • Ketamine 5, 4
  • Sphenopalatine ganglion (SPG) blocks 1

Clinical Algorithm

  1. Assess severity and contraindications

    • Check for cardiovascular disease (affects triptan use)
    • Assess for NSAID contraindications
    • Evaluate pregnancy status
  2. Initiate combination therapy:

    • Dopamine antagonist (prochlorperazine 10 mg IV OR metoclopramide 10 mg IV)
    • PLUS NSAID (ketorolac 30-60 mg IV)
    • PLUS dexamethasone 10-24 mg IV
  3. If inadequate response after 30-60 minutes:

    • Add sumatriptan 6 mg SC (if no cardiovascular contraindications)
    • OR consider GONB
    • OR valproate 500-1000 mg IV
  4. For severe nausea/vomiting:

    • Use non-oral routes from onset
    • Consider prochlorperazine suppository

Important Caveats

  • Medication overuse headache: Warn patients about using acute medications ≥10 days/month for triptans or ≥15 days/month for NSAIDs 6
  • Pregnancy: Most agents contraindicated; DHE has oxytocic properties 3
  • Recurrence: Occurs in 8-12 hours with triptans; can retreat with second dose 3
  • Treatment timing: Administer as early as possible during attack for improved efficacy 3

The 2025 American Headache Society guideline 1 represents the most current evidence and supersedes older recommendations, particularly regarding the strong evidence against opioids and for nerve blocks as first-line options.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.